Japan Tissue Engineering Co., Ltd. (TYO:7774)
Japan · Delayed Price · Currency is JPY 867.00
-1.00 (-0.12%)
Aug 27, 2026, 10:10 AM JST
Japan Tissue Engineering Market Cap
Japan Tissue Engineering has a market cap or net worth of 35.25 billion as of August 26, 2026. Its market cap has increased by 74.30% in one year.
Market Cap
35.25B
Enterprise Value
31.90B
Revenue
2.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
867.00
ChartMarket Cap Chart
Since December 21, 2007, Japan Tissue Engineering's market cap has increased from 5.99B to 35.25B, an increase of 488.24%. That is a compound annual growth rate of 9.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 35.25B | 39.55% |
| Dec 30, 2025 | 25.26B | 34.34% |
| Dec 30, 2024 | 18.80B | -8.50% |
| Dec 29, 2023 | 20.55B | 8.35% |
| Dec 30, 2022 | 18.96B | -17.49% |
| Dec 30, 2021 | 22.99B | -8.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SanBio Company | 78.84B |
| Heartseed | 51.03B |
| Cuorips | 42.87B |
| Healios K.K. | 36.45B |
| Innovacell | 28.58B |
| StemRIM | 22.38B |
| Renascience | 17.94B |
| AnGes | 15.55B |